THC BioMed Intl Ltd. announced that it has appointed Don Shaxon to the company's newly formed Advisory Board. Mr. Shaxon brings 20 years' experience in the capital markets including a successful position as Corporate development Manager with Cannabis Science Inc. where he was instrumental in helping build the company from a small cap company into an industry leader with a market cap that topped $100 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | -.--% | -.--% | -.--% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.39M | |
+38.24% | 6.06B | |
-22.80% | 4.11B | |
+8.95% | 3.4B | |
-19.98% | 2.81B | |
-10.41% | 2.31B | |
+46.41% | 1.95B | |
+48.31% | 1.53B | |
-15.56% | 1.54B | |
-8.05% | 1.51B |
- Stock Market
- Equities
- THC Stock
- News THC Biomed Intl Ltd.
- THC BioMed Intl Ltd. Appoints Don Shaxon to its Advisory Board